Prelude Therapeutics (PRLD) Shareholder's Equity (2019 - 2026)
Prelude Therapeutics (PRLD) Shareholder's Equity (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
502.95 Mn |
| 10 |
Prelude Therapeutics |
314.40 Mn |
169.80 Mn |
- |
60.18 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
60.18 Mn |
| Dec 31, 2025 |
68.64 Mn |
| Sep 30, 2025 |
58.53 Mn |
| Jun 30, 2025 |
75.84 Mn |
| Mar 31, 2025 |
103.18 Mn |
| Dec 31, 2024 |
131.46 Mn |
| Sep 30, 2024 |
156.43 Mn |
| Jun 30, 2024 |
182.28 Mn |
| Mar 31, 2024 |
210.73 Mn |
| Dec 31, 2023 |
237.09 Mn |
| Sep 30, 2023 |
238.26 Mn |
| Jun 30, 2023 |
262.06 Mn |
| Mar 31, 2023 |
175.30 Mn |
| Dec 31, 2022 |
195.44 Mn |
| Sep 30, 2022 |
217.41 Mn |
| Jun 30, 2022 |
240.84 Mn |
| Mar 31, 2022 |
261.81 Mn |
| Dec 31, 2021 |
285.90 Mn |
| Sep 30, 2021 |
311.24 Mn |
| Jun 30, 2021 |
334.36 Mn |
